Arcutis Biotherapeutics, Inc. ARQT Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s compensation and benefits?
- Arcutis Biotherapeutics, Inc. (ARQT) reported compensation and benefits of $10.32M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s compensation and benefits changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s compensation and benefits increased by 12.7% year-over-year, from $9.16M to $10.32M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s compensation and benefits?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s compensation and benefits has grown at a 35.9% compound annual growth rate (CAGR), from $4.43M to $20.53M.